---
figid: PMC5837225__ehx144f4
figtitle: Schematic figure showing that all therapies that act predominantly to lower
  low-density lipoprotein (LDL) act via the LDL receptor pathway to up-regulate LDL
  receptors and thus increase LDL clearance
organisms:
- Homo sapiens
- Oryctolagus cuniculus
- Nicotiana tabacum
organisms_ner:
- NA
pmcid: PMC5837225
filename: ehx144f4.jpg
figlink: /pmc/articles/PMC5837225/figure/ehx144-F4/
number: F4
caption: Schematic figure showing that all therapies that act predominantly to lower
  low-density lipoprotein (LDL) act via the LDL receptor pathway to up-regulate LDL
  receptors and thus increase LDL clearance.
papertitle: Low-density lipoproteins cause atherosclerotic cardiovascular disease.
  1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement
  from the European Atherosclerosis Society Consensus Panel.
reftext: Brian A. Ference, et al. Eur Heart J. 2017 Aug 21;38(32):2459-2472.
year: '2017'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.5257343
figid_alias: PMC5837225__F4
figtype: Figure
redirect_from: /figures/PMC5837225__F4
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5837225__ehx144f4.html
  '@type': Dataset
  description: Schematic figure showing that all therapies that act predominantly
    to lower low-density lipoprotein (LDL) act via the LDL receptor pathway to up-regulate
    LDL receptors and thus increase LDL clearance.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Bile acid
  - bile acids
  - Cholesterol
  - cholesterol
---
